{"filings":[{"id":778637,"accession_number":"0000785161-26-000161","cik":785161,"company_name":"Encompass Health Corp","ticker":"EHC","form_type":"8-K","filed_at":"2026-06-01T20:26:16+00:00","items":["1.01","2.03","9.01"],"status":"ready","headline":"Encompass Health issues $500M 5.875% notes due 2034; to redeem $400M of 4.500% notes due 2028","summary_kind":"llm","event_type":"debt","confidence":"high","bullets":["Issued $500M 5.875% Senior Notes due 2034 at par; net proceeds ~$491.2M after discounts and expenses.","Proceeds to redeem $400M of 4.500% Senior Notes due 2028 and repay $100M under revolving credit facility.","Notes mature June 1, 2034; interest payable semi-annually June 1 and Dec 1 starting Dec 1, 2026.","Notes are senior unsecured, jointly guaranteed by subsidiaries that guarantee other debt.","Company may redeem notes on/after June 1, 2029 at specified prices; prior to that at make-whole premium."],"consensus_eps_estimate":null,"consensus_eps_actual":null,"consensus_revenue_estimate":null,"consensus_revenue_actual":null,"consensus_period":null,"consensus_source":null,"sentiment":"neutral","materiality_score":0.5,"calibrated_materiality_score":0.5,"market_cap_usd":10387135906.5617,"market_cap_bucket":"not_microcap","market_cap_source":"finnhub_profile2","market_cap_as_of_date":"2026-05-28","daily_digest_date":null,"daily_digest_url":null,"daily_digest_rank":null},{"id":468836,"accession_number":"0000785161-26-000156","cik":785161,"company_name":"Encompass Health Corp","ticker":"EHC","form_type":"8-K","filed_at":"2026-05-15T19:24:47+00:00","items":["1.01","8.01","9.01"],"status":"ready","headline":"Encompass Health prices $500M of 5.875% senior notes due 2034 to refinance debt","summary_kind":"llm","event_type":"debt","confidence":"high","bullets":["Issued $500M aggregate principal of 5.875% senior notes due 2034; closing expected May 29, 2026.","Net proceeds plus cash to redeem $400M of 4.500% senior notes due 2028 at par.","Also will repay $100M outstanding under its revolving credit facility.","Wells Fargo Securities acted as representative of the initial purchasers."],"consensus_eps_estimate":null,"consensus_eps_actual":null,"consensus_revenue_estimate":null,"consensus_revenue_actual":null,"consensus_period":null,"consensus_source":null,"sentiment":"neutral","materiality_score":0.52,"calibrated_materiality_score":0.52,"market_cap_usd":10387135906.5617,"market_cap_bucket":"not_microcap","market_cap_source":"finnhub_profile2","market_cap_as_of_date":"2026-05-28","daily_digest_date":null,"daily_digest_url":null,"daily_digest_rank":null},{"id":13524,"accession_number":"0000785161-26-000151","cik":785161,"company_name":"Encompass Health Corp","ticker":"EHC","form_type":"8-K","filed_at":"2026-05-11T20:21:43+00:00","items":["5.07"],"status":"ready","headline":"Encompass Health annual meeting: all director nominees elected, PwC ratified, say-on-pay approved","summary_kind":"llm","event_type":"other_material","confidence":"high","bullets":["All 10 director nominees elected; Mark J. Tarr received highest votes (85.9M for, 0.6M against).","Ratification of PricewaterhouseCoopers as auditor passed with 88.4M for, 3.6M against.","Say-on-pay proposal passed with 83.4M for, 3.0M against.","Broker non-votes totaled 5.6M on director election and say-on-pay, none on auditor ratification.","Over 92.5% of outstanding shares (99.6M) were represented at the meeting."],"consensus_eps_estimate":null,"consensus_eps_actual":null,"consensus_revenue_estimate":null,"consensus_revenue_actual":null,"consensus_period":null,"consensus_source":null,"sentiment":"neutral","materiality_score":0.1,"calibrated_materiality_score":0.1,"market_cap_usd":10387135906.5617,"market_cap_bucket":"not_microcap","market_cap_source":"finnhub_profile2","market_cap_as_of_date":"2026-05-28","daily_digest_date":null,"daily_digest_url":null,"daily_digest_rank":null},{"id":98832,"accession_number":"0000785161-26-000128","cik":785161,"company_name":"Encompass Health Corp","ticker":"EHC","form_type":"8-K","filed_at":"2026-04-30T23:59:59+00:00","items":["2.02","7.01","9.01"],"status":"ready","headline":"Encompass Health files 8-K for Q1 2026 earnings; no specific results in filing body","summary_kind":"llm","event_type":"earnings","confidence":"low","bullets":["Filing references press release (Ex-99.1) and supplemental slides (Ex-99.2) for Q1 2026 results.","No financial figures (revenue, EPS, patient volumes) appear in the 8-K text.","Company discusses non-GAAP measures (adjusted EPS, Adjusted EBITDA, adjusted free cash flow) and forward-looking statements.","Earnings call scheduled for May 1, 2026 at 10:00 AM ET."],"consensus_eps_estimate":1.5119,"consensus_eps_actual":1.93,"consensus_revenue_estimate":null,"consensus_revenue_actual":1586600000.0,"consensus_period":"2026-Q1","consensus_source":"xbrl+finnhub","sentiment":"neutral","materiality_score":0.4,"calibrated_materiality_score":0.4,"market_cap_usd":10387135906.5617,"market_cap_bucket":"not_microcap","market_cap_source":"finnhub_profile2","market_cap_as_of_date":"2026-05-28","daily_digest_date":null,"daily_digest_url":null,"daily_digest_rank":null},{"id":114515,"accession_number":"0000785161-26-000100","cik":785161,"company_name":"Encompass Health Corp","ticker":"EHC","form_type":"8-K","filed_at":"2026-03-10T23:59:59+00:00","items":["1.01","1.02","2.03","9.01"],"status":"ready","headline":"Encompass Health enters $1B revolver with Truist; matures 2031, replaces 2022 facility","summary_kind":"llm","event_type":"debt","confidence":"high","bullets":["New $1.0B revolving credit facility with Truist Bank as administrative agent; maturity extended to March 9, 2031 (from Oct 2027).","Undrawn commitment fee reduced by 5 bps; swingline sublimit increased to $40M (from $25M); 0.10% SOFR adjustment eliminated.","Drew $250M to repay prior credit agreement; also drew $53.6M on new letter of credit subfacility.","Financial covenants: minimum Interest Coverage Ratio 3.00x; maximum Leverage Ratio 4.50x (net of cash), except for significant acquisitions.","Accordion permits up to $1.4B or 100% EBITDA additional commitments, subject to Senior Secured Leverage Ratio ≤ 3.50x."],"consensus_eps_estimate":null,"consensus_eps_actual":null,"consensus_revenue_estimate":null,"consensus_revenue_actual":null,"consensus_period":null,"consensus_source":null,"sentiment":"neutral","materiality_score":0.6,"calibrated_materiality_score":0.6,"market_cap_usd":10387135906.5617,"market_cap_bucket":"not_microcap","market_cap_source":"finnhub_profile2","market_cap_as_of_date":"2026-05-28","daily_digest_date":null,"daily_digest_url":null,"daily_digest_rank":null},{"id":114512,"accession_number":"0000785161-26-000049","cik":785161,"company_name":"Encompass Health Corp","ticker":"EHC","form_type":"8-K/A","filed_at":"2026-02-20T23:59:59+00:00","items":["5.02"],"status":"ready","headline":"Encompass Health appoints Cain Hayes to two board committees","summary_kind":"llm","event_type":"leadership","confidence":"high","bullets":["Cain Hayes appointed to Compensation and Human Capital Committee.","Also appointed to Compliance and Quality of Care Committee.","Appointments effective February 19, 2026.","Mr. Hayes joined the Board on January 30, 2026."],"consensus_eps_estimate":null,"consensus_eps_actual":null,"consensus_revenue_estimate":null,"consensus_revenue_actual":null,"consensus_period":null,"consensus_source":null,"sentiment":"neutral","materiality_score":0.15,"calibrated_materiality_score":0.15,"market_cap_usd":10387135906.5617,"market_cap_bucket":"not_microcap","market_cap_source":"finnhub_profile2","market_cap_as_of_date":"2026-05-28","daily_digest_date":null,"daily_digest_url":null,"daily_digest_rank":null},{"id":114514,"accession_number":"0000785161-26-000028","cik":785161,"company_name":"Encompass Health Corp","ticker":"EHC","form_type":"8-K","filed_at":"2026-02-05T23:59:59+00:00","items":["2.02","7.01","9.01"],"status":"ready","headline":"Encompass Health Reports Q4 and Full Year 2025 Financial Results","summary_kind":"llm","event_type":"earnings","confidence":"medium","bullets":["Press release dated February 5, 2026, covers three months and year ended December 31, 2025.","Company uses same-store comparisons based on hospitals open throughout both full current and prior periods.","Non-GAAP measures include adjusted earnings per share, leverage ratio, Adjusted EBITDA, and adjusted free cash flow.","Earnings call scheduled for 10:00 a.m. Eastern Time on February 6, 2026, to discuss supplemental information."],"consensus_eps_estimate":1.3112,"consensus_eps_actual":5.54,"consensus_revenue_estimate":null,"consensus_revenue_actual":5935200000.0,"consensus_period":"2025-FY","consensus_source":"xbrl+finnhub","sentiment":"neutral","materiality_score":0.8,"calibrated_materiality_score":0.8,"market_cap_usd":10387135906.5617,"market_cap_bucket":"not_microcap","market_cap_source":"finnhub_profile2","market_cap_as_of_date":"2026-05-28","daily_digest_date":null,"daily_digest_url":null,"daily_digest_rank":null},{"id":114513,"accession_number":"0000785161-26-000025","cik":785161,"company_name":"Encompass Health Corp","ticker":"EHC","form_type":"8-K","filed_at":"2026-02-02T23:59:59+00:00","items":["5.02","9.01"],"status":"ready","headline":"Encompass Health elects Cain A. Hayes as independent director","summary_kind":"llm","event_type":"leadership","confidence":"high","bullets":["Cain A. Hayes elected to Encompass Health Board effective January 30, 2026.","Board determined Hayes is independent under NYSE listing standards.","Hayes will receive standard nonemployee director compensation as described in the 2025 proxy statement.","No arrangements or related party transactions underlie Hayes's appointment."],"consensus_eps_estimate":null,"consensus_eps_actual":null,"consensus_revenue_estimate":null,"consensus_revenue_actual":null,"consensus_period":null,"consensus_source":null,"sentiment":"neutral","materiality_score":0.35,"calibrated_materiality_score":0.35,"market_cap_usd":10387135906.5617,"market_cap_bucket":"not_microcap","market_cap_source":"finnhub_profile2","market_cap_as_of_date":"2026-05-28","daily_digest_date":null,"daily_digest_url":null,"daily_digest_rank":null},{"id":130886,"accession_number":"0000785161-25-000118","cik":785161,"company_name":"Encompass Health Corp","ticker":"EHC","form_type":"8-K","filed_at":"2025-12-01T23:59:59+00:00","items":["7.01"],"status":"ready","headline":"Encompass Health reaffirms full-year 2025 guidance ahead of investor meetings","summary_kind":"llm","event_type":"other","confidence":"high","bullets":["Net operating revenue expected $5,905M to $5,955M.","Adjusted EBITDA guidance range of $1,235M to $1,255M.","Adjusted EPS from continuing ops attributed to Encompass Health: $5.22 to $5.37.","Management to meet investors December 2–3, 2025; guidance unchanged from Oct 29, 2025."],"consensus_eps_estimate":null,"consensus_eps_actual":null,"consensus_revenue_estimate":null,"consensus_revenue_actual":null,"consensus_period":null,"consensus_source":null,"sentiment":"neutral","materiality_score":0.2,"calibrated_materiality_score":0.2,"market_cap_usd":10387135906.5617,"market_cap_bucket":"not_microcap","market_cap_source":"finnhub_profile2","market_cap_as_of_date":"2026-05-28","daily_digest_date":null,"daily_digest_url":null,"daily_digest_rank":null},{"id":130885,"accession_number":"0000785161-25-000113","cik":785161,"company_name":"Encompass Health Corp","ticker":"EHC","form_type":"8-K","filed_at":"2025-10-29T23:59:59+00:00","items":["2.02","7.01","9.01"],"status":"ready","headline":"Encompass Health reports Q3 2025 results; specific figures not available in filing excerpt","summary_kind":"llm","event_type":"earnings","confidence":"low","bullets":["Press release and supplemental slides for Q3 2025 furnished; no revenue or EPS extracted from provided text.","Company will discuss results on October 30, 2025 earnings call.","Non-GAAP measures (adjusted EPS, Adjusted EBITDA, adjusted free cash flow) are highlighted in the filing.","Same-store comparisons used; impact of market consolidation and capacity expansions included."],"consensus_eps_estimate":1.2066,"consensus_eps_actual":4.11,"consensus_revenue_estimate":null,"consensus_revenue_actual":4390600000.0,"consensus_period":"2025-Q3","consensus_source":"xbrl+finnhub","sentiment":"neutral","materiality_score":0.3,"calibrated_materiality_score":0.3,"market_cap_usd":10387135906.5617,"market_cap_bucket":"not_microcap","market_cap_source":"finnhub_profile2","market_cap_as_of_date":"2026-05-28","daily_digest_date":null,"daily_digest_url":null,"daily_digest_rank":null},{"id":147457,"accession_number":"0000785161-25-000086","cik":785161,"company_name":"Encompass Health Corp","ticker":"EHC","form_type":"8-K","filed_at":"2025-09-18T23:59:59+00:00","items":["5.02"],"status":"ready","headline":"Director Patricia Maryland retires from Encompass Health board for health reasons","summary_kind":"llm","event_type":"leadership","confidence":"high","bullets":["Patricia Maryland resigned from the board effective September 17, 2025, citing health reasons.","Chairman Greg Carmichael expressed gratitude for her contributions and insights.","No replacement director has been announced as of the filing date."],"consensus_eps_estimate":null,"consensus_eps_actual":null,"consensus_revenue_estimate":null,"consensus_revenue_actual":null,"consensus_period":null,"consensus_source":null,"sentiment":"neutral","materiality_score":0.3,"calibrated_materiality_score":0.3,"market_cap_usd":10387135906.5617,"market_cap_bucket":"not_microcap","market_cap_source":"finnhub_profile2","market_cap_as_of_date":"2026-05-28","daily_digest_date":null,"daily_digest_url":null,"daily_digest_rank":null},{"id":147456,"accession_number":"0000785161-25-000070","cik":785161,"company_name":"Encompass Health Corp","ticker":"EHC","form_type":"8-K","filed_at":"2025-09-12T23:59:59+00:00","items":["7.01"],"status":"ready","headline":"Encompass Health reaffirms FY2025 guidance during investor meetings","summary_kind":"llm","event_type":"other_material","confidence":"high","bullets":["Net operating revenue guidance of $5.88B-$5.98B for FY2025.","Adjusted EBITDA guided at $1.22B-$1.25B; adjusted EPS $5.12-$5.34.","Reiteration provided at meetings on Sept 12, Oct 1, and Oct 6, 2025.","Previous guidance from Aug 4/5, 2025 remains unchanged."],"consensus_eps_estimate":null,"consensus_eps_actual":null,"consensus_revenue_estimate":null,"consensus_revenue_actual":null,"consensus_period":null,"consensus_source":null,"sentiment":"neutral","materiality_score":0.5,"calibrated_materiality_score":0.5,"market_cap_usd":10387135906.5617,"market_cap_bucket":"not_microcap","market_cap_source":"finnhub_profile2","market_cap_as_of_date":"2026-05-28","daily_digest_date":null,"daily_digest_url":null,"daily_digest_rank":null},{"id":147455,"accession_number":"0000785161-25-000049","cik":785161,"company_name":"Encompass Health Corp","ticker":"EHC","form_type":"8-K","filed_at":"2025-08-04T23:59:59+00:00","items":["2.02","7.01","9.01"],"status":"ready","headline":"Encompass Health Q2 2025 results filed; specific figures in exhibits not provided in text","summary_kind":"llm","event_type":"earnings","confidence":"low","bullets":["Press release for Q2 2025 results issued on August 4, 2025, but no financial data appears in the filing body.","Supplemental information for August 5 earnings call attached as Exhibit 99.2; details not available here.","Filing discusses non-GAAP measures and forward-looking statements but lacks actual revenue, EPS, or guidance numbers."],"consensus_eps_estimate":1.2212,"consensus_eps_actual":2.87,"consensus_revenue_estimate":null,"consensus_revenue_actual":2913100000.0,"consensus_period":"2025-Q2","consensus_source":"xbrl+finnhub","sentiment":"neutral","materiality_score":0.4,"calibrated_materiality_score":0.4,"market_cap_usd":10387135906.5617,"market_cap_bucket":"not_microcap","market_cap_source":"finnhub_profile2","market_cap_as_of_date":"2026-05-28","daily_digest_date":null,"daily_digest_url":null,"daily_digest_rank":null},{"id":166096,"accession_number":"0000785161-25-000033","cik":785161,"company_name":"Encompass Health Corp","ticker":"EHC","form_type":"8-K","filed_at":"2025-06-25T23:59:59+00:00","items":["7.01","9.01"],"status":"ready","headline":"Encompass Health publishes Investor Reference Book with business overview and strategy","summary_kind":"llm","event_type":"other_material","confidence":"low","bullets":["Investor Reference Book published June 25, 2025, covering company overview, industry, business outlook, growth strategy, and operational initiatives.","No specific financial data or guidance changes provided in the filing or attached exhibit.","Document available on Encompass Health's investor relations website."],"consensus_eps_estimate":null,"consensus_eps_actual":null,"consensus_revenue_estimate":null,"consensus_revenue_actual":null,"consensus_period":null,"consensus_source":null,"sentiment":"neutral","materiality_score":0.25,"calibrated_materiality_score":0.25,"market_cap_usd":10387135906.5617,"market_cap_bucket":"not_microcap","market_cap_source":"finnhub_profile2","market_cap_as_of_date":"2026-05-28","daily_digest_date":null,"daily_digest_url":null,"daily_digest_rank":null},{"id":166095,"accession_number":"0000785161-25-000028","cik":785161,"company_name":"Encompass Health Corp","ticker":"EHC","form_type":"8-K","filed_at":"2025-06-03T23:59:59+00:00","items":["7.01"],"status":"ready","headline":"Encompass Health reaffirms FY2025 guidance ahead of investor meetings","summary_kind":"llm","event_type":"other_material","confidence":"high","bullets":["Reiterated FY2025 net operating revenue $5,850M-$5,925M.","Adjusted EBITDA reaffirmed at $1,185M-$1,220M.","Adjusted EPS from continuing ops reaffirmed at $4.85-$5.10.","Senior management to meet investors on June 4 and June 18, 2025."],"consensus_eps_estimate":null,"consensus_eps_actual":null,"consensus_revenue_estimate":null,"consensus_revenue_actual":null,"consensus_period":null,"consensus_source":null,"sentiment":"neutral","materiality_score":0.4,"calibrated_materiality_score":0.4,"market_cap_usd":10387135906.5617,"market_cap_bucket":"not_microcap","market_cap_source":"finnhub_profile2","market_cap_as_of_date":"2026-05-28","daily_digest_date":null,"daily_digest_url":null,"daily_digest_rank":null},{"id":166094,"accession_number":"0000785161-25-000025","cik":785161,"company_name":"Encompass Health Corp","ticker":"EHC","form_type":"8-K","filed_at":"2025-05-02T23:59:59+00:00","items":["5.02","5.07","9.01"],"status":"ready","headline":"Encompass Health shareholders approve 2025 Omnibus Incentive Plan; re-elect all 10 directors","summary_kind":"llm","event_type":"other_material","confidence":"high","bullets":["93.9% of shares represented at meeting; each director nominee received >96% votes for.","PricewaterhouseCoopers ratified as independent auditor with 95.6% votes for.","Say-on-pay executive compensation approved with 97.6% votes for.","2025 Omnibus Performance Incentive Plan approved; 12M shares authorized with 2.65 fungibility ratio for full-value awards.","Plan replaces 2016 Omnibus Equity Incentive Plan; effective May 2, 2025."],"consensus_eps_estimate":null,"consensus_eps_actual":null,"consensus_revenue_estimate":null,"consensus_revenue_actual":null,"consensus_period":null,"consensus_source":null,"sentiment":"neutral","materiality_score":0.5,"calibrated_materiality_score":0.5,"market_cap_usd":10387135906.5617,"market_cap_bucket":"not_microcap","market_cap_source":"finnhub_profile2","market_cap_as_of_date":"2026-05-28","daily_digest_date":null,"daily_digest_url":null,"daily_digest_rank":null},{"id":166093,"accession_number":"0000785161-25-000018","cik":785161,"company_name":"Encompass Health Corp","ticker":"EHC","form_type":"8-K","filed_at":"2025-04-24T23:59:59+00:00","items":["2.02","7.01","5.02","9.01"],"status":"ready","headline":"Encompass Health appoints Patrick Tuer as EVP/COO; Q1 earnings filed without specific figures","summary_kind":"llm","event_type":"leadership","confidence":"medium","bullets":["Patrick Tuer (41) named EVP & COO effective April 24, 2025; previously Group President overseeing 69 hospitals.","Tuer's compensation: base salary $450,000, bonus target 65% of base, LTI target 150% of base.","Q1 2025 earnings press release was referenced but no financial data is present in the provided filing text."],"consensus_eps_estimate":null,"consensus_eps_actual":null,"consensus_revenue_estimate":null,"consensus_revenue_actual":null,"consensus_period":null,"consensus_source":null,"sentiment":"neutral","materiality_score":0.6,"calibrated_materiality_score":0.6,"market_cap_usd":10387135906.5617,"market_cap_bucket":"not_microcap","market_cap_source":"finnhub_profile2","market_cap_as_of_date":"2026-05-28","daily_digest_date":null,"daily_digest_url":null,"daily_digest_rank":null},{"id":183604,"accession_number":"0000785161-25-000006","cik":785161,"company_name":"Encompass Health Corp","ticker":"EHC","form_type":"8-K","filed_at":"2025-02-21T23:59:59+00:00","items":["5.02"],"status":"ready","headline":"Encompass Health boosts CEO 2025 base salary to $1.1M, aircraft allowance to $100K","summary_kind":"llm","event_type":"other_material","confidence":"high","bullets":["CEO Mark Tarr: 2025 base salary $1.1M (+4.8%), target cash bonus $1.485M, target equity $6M.","CFO Douglas Coltharp: 2025 base $750K (+7.1%), target bonus $750K, equity $2.25M.","GC Patrick Darby: base unchanged at $625K, target bonus $500K (+6.7%), equity $1.09375M.","CMO Elissa Charbonneau: base $435K (+4.8%), target bonus $261K, equity $478.5K.","CEO's annual personal aircraft usage allowance increased from ~$75K to $100K."],"consensus_eps_estimate":null,"consensus_eps_actual":null,"consensus_revenue_estimate":null,"consensus_revenue_actual":null,"consensus_period":null,"consensus_source":null,"sentiment":"neutral","materiality_score":0.35,"calibrated_materiality_score":0.35,"market_cap_usd":10387135906.5617,"market_cap_bucket":"not_microcap","market_cap_source":"finnhub_profile2","market_cap_as_of_date":"2026-05-28","daily_digest_date":null,"daily_digest_url":null,"daily_digest_rank":null},{"id":183603,"accession_number":"0000785161-25-000003","cik":785161,"company_name":"Encompass Health Corp","ticker":"EHC","form_type":"8-K","filed_at":"2025-02-06T23:59:59+00:00","items":["2.02","7.01","9.01"],"status":"ready","headline":"Encompass Health reports Q4 and FY2024 earnings; detailed results not extractable from provided exhibits","summary_kind":"llm","event_type":"earnings","confidence":"low","bullets":["Earnings press release (Ex 99.1) and supplemental slides (Ex 99.2) referenced but not included in filing text.","Filing body discusses non-GAAP measures and forward-looking statements; no specific revenue or EPS figures available.","Company filed 8-K on Feb 6, 2025 for results for three months and year ended December 31, 2024.","Non-GAAP metrics described (adjusted EPS, EBITDA, free cash flow) with reconciliations in missing exhibits.","Earnings call scheduled for Feb 7, 2025; supplemental slides to be used."],"consensus_eps_estimate":null,"consensus_eps_actual":4.46,"consensus_revenue_estimate":null,"consensus_revenue_actual":5373200000.0,"consensus_period":"2024-FY","consensus_source":"xbrl_only","sentiment":"neutral","materiality_score":0.3,"calibrated_materiality_score":0.3,"market_cap_usd":10387135906.5617,"market_cap_bucket":"not_microcap","market_cap_source":"finnhub_profile2","market_cap_as_of_date":"2026-05-28","daily_digest_date":null,"daily_digest_url":null,"daily_digest_rank":null},{"id":200190,"accession_number":"0000785161-24-000047","cik":785161,"company_name":"Encompass Health Corp","ticker":"EHC","form_type":"8-K","filed_at":"2024-10-28T23:59:59+00:00","items":["2.02","7.01","9.01"],"status":"ready","headline":"Encompass Health reports Q3 2024 earnings; details not available in exhibits","summary_kind":"llm","event_type":"earnings","confidence":"low","bullets":["Press release issued on October 28, 2024 for three and nine months ended September 30, 2024.","Exhibit 99.1 and 99.2 referenced but no specific financial figures provided in the filing text.","Earnings call scheduled for October 29, 2024 at 10:00 a.m. ET.","Adjusted EBITDA, adjusted EPS, and adjusted free cash flow are non-GAAP measures discussed."],"consensus_eps_estimate":null,"consensus_eps_actual":3.28,"consensus_revenue_estimate":null,"consensus_revenue_actual":3968200000.0,"consensus_period":"2024-Q3","consensus_source":"xbrl_only","sentiment":"neutral","materiality_score":0.3,"calibrated_materiality_score":0.3,"market_cap_usd":10387135906.5617,"market_cap_bucket":"not_microcap","market_cap_source":"finnhub_profile2","market_cap_as_of_date":"2026-05-28","daily_digest_date":null,"daily_digest_url":null,"daily_digest_rank":null},{"id":216213,"accession_number":"0000785161-24-000040","cik":785161,"company_name":"Encompass Health Corp","ticker":"EHC","form_type":"8-K","filed_at":"2024-08-05T23:59:59+00:00","items":["2.02","7.01","9.01"],"status":"ready","headline":"Encompass Health reports Q2 2024 results; specifics unavailable in filing text","summary_kind":"llm","event_type":"earnings","confidence":"low","bullets":["Encompass Health issued press release on Aug 5, 2024 covering Q2 2024 financial results.","Supplemental information for Aug 6 earnings call also furnished (Exhibit 99.2).","Filing notes use of non-GAAP measures: adjusted EPS, Adjusted EBITDA, adjusted free cash flow.","No specific revenue, EPS, or guidance figures present in the provided filing excerpt."],"consensus_eps_estimate":null,"consensus_eps_actual":2.22,"consensus_revenue_estimate":null,"consensus_revenue_actual":2617200000.0,"consensus_period":"2024-Q2","consensus_source":"xbrl_only","sentiment":"neutral","materiality_score":0.5,"calibrated_materiality_score":0.5,"market_cap_usd":10387135906.5617,"market_cap_bucket":"not_microcap","market_cap_source":"finnhub_profile2","market_cap_as_of_date":"2026-05-28","daily_digest_date":null,"daily_digest_url":null,"daily_digest_rank":null},{"id":235757,"accession_number":"0000785161-24-000037","cik":785161,"company_name":"Encompass Health Corp","ticker":"EHC","form_type":"8-K","filed_at":"2024-06-21T23:59:59+00:00","items":["7.01","9.01"],"status":"ready","headline":"Encompass Health publishes Investor Reference Book covering business outlook and growth strategy","summary_kind":"llm","event_type":"other_material","confidence":"medium","bullets":["Investor Reference Book published June 21, 2024 includes overview, business outlook, growth strategy, and operational initiatives.","Non-GAAP measures discussed: leverage ratio, Adjusted EBITDA, and adjusted free cash flow.","Forward-looking statements with risk factors: healthcare regulation, reimbursement, competition, cyber incidents.","No new financial results or guidance changes disclosed; document compiles existing strategy and plans."],"consensus_eps_estimate":null,"consensus_eps_actual":null,"consensus_revenue_estimate":null,"consensus_revenue_actual":null,"consensus_period":null,"consensus_source":null,"sentiment":"neutral","materiality_score":0.2,"calibrated_materiality_score":0.2,"market_cap_usd":10387135906.5617,"market_cap_bucket":"not_microcap","market_cap_source":"finnhub_profile2","market_cap_as_of_date":"2026-05-28","daily_digest_date":null,"daily_digest_url":null,"daily_digest_rank":null},{"id":235756,"accession_number":"0000785161-24-000034","cik":785161,"company_name":"Encompass Health Corp","ticker":"EHC","form_type":"8-K","filed_at":"2024-05-29T23:59:59+00:00","items":["7.01"],"status":"ready","headline":"Encompass Health reaffirms FY2024 guidance: revenue $5.25B-$5.325B, Adj. EBITDA $1.03B-$1.065B, Adj. EPS $3.86-$4.11","summary_kind":"llm","event_type":"other","confidence":"high","bullets":["Reiterated full-year 2024 net operating revenue guidance of $5,250M to $5,325M.","Reaffirmed Adjusted EBITDA guidance of $1,030M to $1,065M for 2024.","Adjusted diluted EPS from continuing ops expected between $3.86 and $4.11.","Fireside chat at Leerink Partners Healthcare Crossroads Conference on May 30, 2024."],"consensus_eps_estimate":null,"consensus_eps_actual":null,"consensus_revenue_estimate":null,"consensus_revenue_actual":null,"consensus_period":null,"consensus_source":null,"sentiment":"neutral","materiality_score":0.4,"calibrated_materiality_score":0.4,"market_cap_usd":10387135906.5617,"market_cap_bucket":"not_microcap","market_cap_source":"finnhub_profile2","market_cap_as_of_date":"2026-05-28","daily_digest_date":null,"daily_digest_url":null,"daily_digest_rank":null},{"id":235755,"accession_number":"0000785161-24-000031","cik":785161,"company_name":"Encompass Health Corp","ticker":"EHC","form_type":"8-K","filed_at":"2024-05-06T23:59:59+00:00","items":["5.07","7.01"],"status":"ready","headline":"Encompass Health shareholders elect directors, approve executive pay; Greg Carmichael named Chairman","summary_kind":"llm","event_type":"other_material","confidence":"high","bullets":["All 10 board nominees elected with ~88-89M votes for; 4.9M broker non-votes on advisory items.","Ratification of PwC as auditor passed: 90.9M for, 3.3M against.","Say-on-pay proposal approved: 87.4M for, 1.8M against.","Shareholder DEI report proposal defeated: 25.9M for, 63.3M against.","Board elected Greg Carmichael as Chairman; he is exec chair of City National Bank (RBC subsidiary)."],"consensus_eps_estimate":null,"consensus_eps_actual":null,"consensus_revenue_estimate":null,"consensus_revenue_actual":null,"consensus_period":null,"consensus_source":null,"sentiment":"neutral","materiality_score":0.5,"calibrated_materiality_score":0.5,"market_cap_usd":10387135906.5617,"market_cap_bucket":"not_microcap","market_cap_source":"finnhub_profile2","market_cap_as_of_date":"2026-05-28","daily_digest_date":null,"daily_digest_url":null,"daily_digest_rank":null},{"id":235754,"accession_number":"0000785161-24-000025","cik":785161,"company_name":"Encompass Health Corp","ticker":"EHC","form_type":"8-K","filed_at":"2024-04-24T23:59:59+00:00","items":["2.02","7.01","9.01"],"status":"ready","headline":"Encompass Health reports Q1 2024 earnings; figures not extractable from provided text","summary_kind":"llm","event_type":"earnings","confidence":"low","bullets":["The 8-K references a press release (Exhibit 99.1) and supplemental slides (Exhibit 99.2) for Q1 2024 results.","Actual revenue, EPS, and other key metrics are missing from the filing text supplied; exhibits appear truncated.","Non-GAAP definitions and forward-looking statements are included, but no concrete earnings numbers are visible.","Investors should refer to the full press release and earnings call materials for specific financial data."],"consensus_eps_estimate":null,"consensus_eps_actual":1.1,"consensus_revenue_estimate":null,"consensus_revenue_actual":1316000000.0,"consensus_period":"2024-Q1","consensus_source":"xbrl_only","sentiment":"neutral","materiality_score":0.5,"calibrated_materiality_score":0.5,"market_cap_usd":10387135906.5617,"market_cap_bucket":"not_microcap","market_cap_source":"finnhub_profile2","market_cap_as_of_date":"2026-05-28","daily_digest_date":null,"daily_digest_url":null,"daily_digest_rank":null},{"id":253509,"accession_number":"0000785161-24-000015","cik":785161,"company_name":"Encompass Health Corp","ticker":"EHC","form_type":"8-K","filed_at":"2024-03-11T23:59:59+00:00","items":["7.01"],"status":"ready","headline":"Encompass Health reiterates FY2024 guidance at Barclays conference; no changes","summary_kind":"llm","event_type":"other","confidence":"high","bullets":["Company to present at Barclays Global Healthcare Conference on March 12, 2024, with CEO and CFO.","Reaffirms FY2024 guidance: net operating revenue $5,200M-$5,300M.","Adjusted EBITDA reaffirmed at $1,015M-$1,055M; adjusted EPS $3.77-$4.06.","Guidance unchanged from Feb 7 8-K and Feb 8 earnings call.","No new financial or operational updates disclosed."],"consensus_eps_estimate":null,"consensus_eps_actual":null,"consensus_revenue_estimate":null,"consensus_revenue_actual":null,"consensus_period":null,"consensus_source":null,"sentiment":"neutral","materiality_score":0.2,"calibrated_materiality_score":0.2,"market_cap_usd":10387135906.5617,"market_cap_bucket":"not_microcap","market_cap_source":"finnhub_profile2","market_cap_as_of_date":"2026-05-28","daily_digest_date":null,"daily_digest_url":null,"daily_digest_rank":null},{"id":253508,"accession_number":"0000785161-24-000012","cik":785161,"company_name":"Encompass Health Corp","ticker":"EHC","form_type":"8-K","filed_at":"2024-03-04T23:59:59+00:00","items":["5.02"],"status":"ready","headline":"Encompass Health boosts CEO target LTI to $5.425M, GC salary to $625K","summary_kind":"llm","event_type":"leadership","confidence":"high","bullets":["Board approved increase in CEO Mark Tarr's target long-term incentive from $5.17M to $5.425M.","Committee increased General Counsel Patrick Darby's base salary from $550K to $625K.","Darby's total direct compensation target is $2.125M (salary + bonus + equity).","Changes effective upon approval at February 27-28, 2024 Board meeting."],"consensus_eps_estimate":null,"consensus_eps_actual":null,"consensus_revenue_estimate":null,"consensus_revenue_actual":null,"consensus_period":null,"consensus_source":null,"sentiment":"neutral","materiality_score":0.3,"calibrated_materiality_score":0.3,"market_cap_usd":10387135906.5617,"market_cap_bucket":"not_microcap","market_cap_source":"finnhub_profile2","market_cap_as_of_date":"2026-05-28","daily_digest_date":null,"daily_digest_url":null,"daily_digest_rank":null},{"id":253507,"accession_number":"0000785161-24-000006","cik":785161,"company_name":"Encompass Health Corp","ticker":"EHC","form_type":"8-K","filed_at":"2024-02-27T23:59:59+00:00","items":["7.01"],"status":"ready","headline":"Encompass Health discloses cyber incident at vendor Change Healthcare affecting claims","summary_kind":"llm","event_type":"cyber","confidence":"high","bullets":["Received notice Feb 21, 2024 from Change Healthcare (UnitedHealth subsidiary) of a cybersecurity incident.","Encompass Health severed connections; no compromise of its own systems identified to date.","Operations and patient care unaffected except for payment claims submission; delays possible if service not restored.","Change Healthcare has not provided restoration timeline; Encompass Health has not deemed the incident material."],"consensus_eps_estimate":null,"consensus_eps_actual":null,"consensus_revenue_estimate":null,"consensus_revenue_actual":null,"consensus_period":null,"consensus_source":null,"sentiment":"negative","materiality_score":0.4,"calibrated_materiality_score":0.4,"market_cap_usd":10387135906.5617,"market_cap_bucket":"not_microcap","market_cap_source":"finnhub_profile2","market_cap_as_of_date":"2026-05-28","daily_digest_date":null,"daily_digest_url":null,"daily_digest_rank":null},{"id":253506,"accession_number":"0000785161-24-000003","cik":785161,"company_name":"Encompass Health Corp","ticker":"EHC","form_type":"8-K","filed_at":"2024-02-07T23:59:59+00:00","items":["2.02","7.01","9.01"],"status":"ready","headline":"Encompass Health reports Q4 and FY 2023 results; no specific figures in filing text","summary_kind":"llm","event_type":"earnings","confidence":"low","bullets":["Q4 and full-year 2023 financial results announced on Feb 7, 2024.","Press release includes non-GAAP measures: adjusted EPS, Adjusted EBITDA, adjusted free cash flow.","Supplemental slides provided for Feb 8 earnings call; specific revenue and EPS not extractable from this filing.","Company uses same-store comparisons for performance metrics.","Forward-looking statements and reconciliation of non-GAAP measures are included."],"consensus_eps_estimate":null,"consensus_eps_actual":3.47,"consensus_revenue_estimate":null,"consensus_revenue_actual":4801200000.0,"consensus_period":"2023-FY","consensus_source":"xbrl_only","sentiment":"neutral","materiality_score":0.5,"calibrated_materiality_score":0.5,"market_cap_usd":10387135906.5617,"market_cap_bucket":"not_microcap","market_cap_source":"finnhub_profile2","market_cap_as_of_date":"2026-05-28","daily_digest_date":null,"daily_digest_url":null,"daily_digest_rank":null},{"id":270977,"accession_number":"0000785161-23-000073","cik":785161,"company_name":"Encompass Health Corp","ticker":"EHC","form_type":"8-K","filed_at":"2023-11-27T23:59:59+00:00","items":["5.02","9.01"],"status":"ready","headline":"Encompass Health appoints Edward M. Christie III to Board, expanding to 12 members","summary_kind":"llm","event_type":"leadership","confidence":"high","bullets":["Edward M. Christie III appointed as independent director, effective Nov 27, 2023.","Board size increased from 11 to 12 to accommodate the new seat.","Mr. Christie appointed to the Audit Committee.","He will receive standard non-employee director compensation as described in proxy.","No arrangements or related party transactions with any other person."],"consensus_eps_estimate":null,"consensus_eps_actual":null,"consensus_revenue_estimate":null,"consensus_revenue_actual":null,"consensus_period":null,"consensus_source":null,"sentiment":"neutral","materiality_score":0.2,"calibrated_materiality_score":0.2,"market_cap_usd":10387135906.5617,"market_cap_bucket":"not_microcap","market_cap_source":"finnhub_profile2","market_cap_as_of_date":"2026-05-28","daily_digest_date":null,"daily_digest_url":null,"daily_digest_rank":null},{"id":270976,"accession_number":"0000785161-23-000061","cik":785161,"company_name":"Encompass Health Corp","ticker":"EHC","form_type":"8-K","filed_at":"2023-10-26T23:59:59+00:00","items":["2.02","7.01","9.01"],"status":"ready","headline":"Encompass Health reports Q3 2023 results; specific financial data not provided in filing text","summary_kind":"llm","event_type":"earnings","confidence":"low","bullets":["Encompass Health issued a press release on Oct 26, 2023, reporting Q3 2023 results.","The press release (Exhibit 99.1) and supplemental slides (Exhibit 99.2) are furnished but their financial data is not extractable from the provided text.","No specific revenue, EPS, or guidance figures are available in the filing body; exhibits lack substantive numbers.","The company uses non-GAAP measures, but actual values are not present in the given excerpt."],"consensus_eps_estimate":null,"consensus_eps_actual":2.62,"consensus_revenue_estimate":null,"consensus_revenue_actual":3554400000.0,"consensus_period":"2023-Q3","consensus_source":"xbrl_only","sentiment":"neutral","materiality_score":0.3,"calibrated_materiality_score":0.3,"market_cap_usd":10387135906.5617,"market_cap_bucket":"not_microcap","market_cap_source":"finnhub_profile2","market_cap_as_of_date":"2026-05-28","daily_digest_date":null,"daily_digest_url":null,"daily_digest_rank":null},{"id":287867,"accession_number":"0000785161-23-000058","cik":785161,"company_name":"Encompass Health Corp","ticker":"EHC","form_type":"8-K","filed_at":"2023-09-27T23:59:59+00:00","items":["7.01","9.01"],"status":"ready","headline":"Encompass Health reaffirms 5-year growth targets; RCD affirmation >95% in Alabama","summary_kind":"llm","event_type":"other_material","confidence":"high","bullets":["Five-year targets (2023-27): 6-10 de novos/year, 80-120 bed additions/year, 6-8% discharge CAGR.","Q3 volume trends positive; RCD in Alabama: ~440 records submitted, >95% affirmation rate vs 80% target.","H1 2023 adjusted EBITDA $478.6M; adjusted EPS from continuing ops $1.83 (diluted).","2023 interest expense estimate $145-155M; amortization approx $10M.","Non-GAAP measures reconciled; company reiterates focus on organic growth and regulatory initiatives."],"consensus_eps_estimate":null,"consensus_eps_actual":null,"consensus_revenue_estimate":null,"consensus_revenue_actual":null,"consensus_period":null,"consensus_source":null,"sentiment":"positive","materiality_score":0.6,"calibrated_materiality_score":0.6,"market_cap_usd":10387135906.5617,"market_cap_bucket":"not_microcap","market_cap_source":"finnhub_profile2","market_cap_as_of_date":"2026-05-28","daily_digest_date":null,"daily_digest_url":null,"daily_digest_rank":null},{"id":287866,"accession_number":"0000785161-23-000049","cik":785161,"company_name":"Encompass Health Corp","ticker":"EHC","form_type":"8-K","filed_at":"2023-08-01T23:59:59+00:00","items":["2.02","7.01","9.01"],"status":"ready","headline":"Encompass Health reports Q2 2023 earnings; details unavailable in provided text","summary_kind":"llm","event_type":"earnings","confidence":"low","bullets":["Filing states press release and supplemental information attached as Exhibits 99.1 and 99.2.","Exhibit text not included in the prompt; no specific financial figures can be extracted.","Event is earnings release for three and six months ended June 30, 2023.","Company uses non-GAAP measures; reconciliations included in attachments."],"consensus_eps_estimate":null,"consensus_eps_actual":1.77,"consensus_revenue_estimate":null,"consensus_revenue_actual":2347500000.0,"consensus_period":"2023-Q2","consensus_source":"xbrl_only","sentiment":"neutral","materiality_score":0.3,"calibrated_materiality_score":0.3,"market_cap_usd":10387135906.5617,"market_cap_bucket":"not_microcap","market_cap_source":"finnhub_profile2","market_cap_as_of_date":"2026-05-28","daily_digest_date":null,"daily_digest_url":null,"daily_digest_rank":null},{"id":287865,"accession_number":"0000785161-23-000046","cik":785161,"company_name":"Encompass Health Corp","ticker":"EHC","form_type":"8-K","filed_at":"2023-07-25T23:59:59+00:00","items":["5.02","9.01"],"status":"ready","headline":"Encompass Health adopts clawback policy to comply with SEC Rule 10D-1 and NYSE listing standards","summary_kind":"llm","event_type":"regulatory","confidence":"high","bullets":["Board approved amended clawback policy on July 20, 2023, requiring mandatory recovery of erroneous incentive-based compensation from current and former executive officers upon accounting restatement.","Change in control and executive severance plans amended to explicitly subject benefits to the clawback policy.","Policy applies to all officers in senior management bonus and long-term incentive plans, with new compliance terms for NYSE listing standards."],"consensus_eps_estimate":null,"consensus_eps_actual":null,"consensus_revenue_estimate":null,"consensus_revenue_actual":null,"consensus_period":null,"consensus_source":null,"sentiment":"neutral","materiality_score":0.25,"calibrated_materiality_score":0.25,"market_cap_usd":10387135906.5617,"market_cap_bucket":"not_microcap","market_cap_source":"finnhub_profile2","market_cap_as_of_date":"2026-05-28","daily_digest_date":null,"daily_digest_url":null,"daily_digest_rank":null},{"id":308207,"accession_number":"0000785161-23-000040","cik":785161,"company_name":"Encompass Health Corp","ticker":"EHC","form_type":"8-K","filed_at":"2023-05-31T23:59:59+00:00","items":["7.01","9.01"],"status":"ready","headline":"Encompass Health publishes Investor Reference Book with business overview and growth strategy","summary_kind":"llm","event_type":"other","confidence":"medium","bullets":["Reference book covers company overview, industry landscape, business outlook, and growth strategy.","Includes non-GAAP metrics: leverage ratio, Adjusted EBITDA, and adjusted free cash flow reconciliations.","No specific financial results or guidance changes announced; filing is a routine investor update."],"consensus_eps_estimate":null,"consensus_eps_actual":null,"consensus_revenue_estimate":null,"consensus_revenue_actual":null,"consensus_period":null,"consensus_source":null,"sentiment":"neutral","materiality_score":0.2,"calibrated_materiality_score":0.2,"market_cap_usd":10387135906.5617,"market_cap_bucket":"not_microcap","market_cap_source":"finnhub_profile2","market_cap_as_of_date":"2026-05-28","daily_digest_date":null,"daily_digest_url":null,"daily_digest_rank":null},{"id":308206,"accession_number":"0000785161-23-000037","cik":785161,"company_name":"Encompass Health Corp","ticker":"EHC","form_type":"8-K","filed_at":"2023-05-19T23:59:59+00:00","items":["7.01"],"status":"ready","headline":"Encompass Health reiterates FY2023 guidance at investor meeting on May 22","summary_kind":"llm","event_type":"other_material","confidence":"high","bullets":["Reaffirms FY2023 net operating revenue of $4,700M-$4,770M.","Reaffirms FY2023 Adjusted EBITDA of $870M-$910M.","Reaffirms FY2023 Adjusted EPS of $2.94-$3.23.","CEO Mark Tarr and CFO Doug Coltharp to participate in investor meeting in Birmingham, AL on May 22, 2023.","Guidance unchanged from April 27, 2023 earnings release and April 28, 2023 conference call."],"consensus_eps_estimate":null,"consensus_eps_actual":null,"consensus_revenue_estimate":null,"consensus_revenue_actual":null,"consensus_period":null,"consensus_source":null,"sentiment":"neutral","materiality_score":0.35,"calibrated_materiality_score":0.35,"market_cap_usd":10387135906.5617,"market_cap_bucket":"not_microcap","market_cap_source":"finnhub_profile2","market_cap_as_of_date":"2026-05-28","daily_digest_date":null,"daily_digest_url":null,"daily_digest_rank":null},{"id":308205,"accession_number":"0000785161-23-000034","cik":785161,"company_name":"Encompass Health Corp","ticker":"EHC","form_type":"8-K","filed_at":"2023-05-08T23:59:59+00:00","items":["5.07"],"status":"ready","headline":"Encompass Health holds 2023 annual meeting; all director nominees elected, say-on-pay approved","summary_kind":"llm","event_type":"other","confidence":"high","bullets":["All 11 director nominees elected with >80M votes for each; top vote-getter Mark Tarr at 86.3M.","Ratification of PricewaterhouseCoopers as auditor passed with 90.1M votes for, 2.5M against.","Say-on-pay compensation approved (82.1M for, 5.3M against); annual frequency adopted with 85.3M for 1 year.","Quorum of 92.5% of outstanding shares represented at the meeting."],"consensus_eps_estimate":null,"consensus_eps_actual":null,"consensus_revenue_estimate":null,"consensus_revenue_actual":null,"consensus_period":null,"consensus_source":null,"sentiment":"neutral","materiality_score":0.1,"calibrated_materiality_score":0.1,"market_cap_usd":10387135906.5617,"market_cap_bucket":"not_microcap","market_cap_source":"finnhub_profile2","market_cap_as_of_date":"2026-05-28","daily_digest_date":null,"daily_digest_url":null,"daily_digest_rank":null},{"id":308204,"accession_number":"0000785161-23-000029","cik":785161,"company_name":"Encompass Health Corp","ticker":"EHC","form_type":"8-K","filed_at":"2023-04-27T23:59:59+00:00","items":["2.02","7.01","9.01"],"status":"ready","headline":"Encompass Health reports Q1 2023 earnings; specific results not available in filing text","summary_kind":"llm","event_type":"earnings","confidence":"low","bullets":["Company issued press release for Q1 2023 financial results on April 27, 2023.","Exhibits attached but financial details (revenue, EPS, etc.) not included in the provided text.","Supplemental information for earnings call contains only forward-looking statements in the excerpt.","Investors should obtain the full earnings release for actual financial data."],"consensus_eps_estimate":null,"consensus_eps_actual":0.87,"consensus_revenue_estimate":null,"consensus_revenue_actual":1160400000.0,"consensus_period":"2023-Q1","consensus_source":"xbrl_only","sentiment":"neutral","materiality_score":0.3,"calibrated_materiality_score":0.3,"market_cap_usd":10387135906.5617,"market_cap_bucket":"not_microcap","market_cap_source":"finnhub_profile2","market_cap_as_of_date":"2026-05-28","daily_digest_date":null,"daily_digest_url":null,"daily_digest_rank":null},{"id":327068,"accession_number":"0000785161-23-000019","cik":785161,"company_name":"Encompass Health Corp","ticker":"EHC","form_type":"8-K","filed_at":"2023-03-14T23:59:59+00:00","items":["7.01"],"status":"ready","headline":"Encompass Health reiterates FY2023 guidance; Q1 rehab discharge growth strong through February","summary_kind":"llm","event_type":"other_material","confidence":"high","bullets":["Reaffirms FY2023 net operating revenue guidance of $4.68B-$4.76B and adjusted EBITDA of $860M-$900M.","Reaffirms adjusted EPS guidance of $2.87-$3.16.","Inpatient rehabilitation discharge growth remained strong through February; anticipates seasonal March impact from spring break.","CEO Mark Tarr and CFO Doug Coltharp to participate in Barclays Global Healthcare Conference on March 15."],"consensus_eps_estimate":null,"consensus_eps_actual":null,"consensus_revenue_estimate":null,"consensus_revenue_actual":null,"consensus_period":null,"consensus_source":null,"sentiment":"neutral","materiality_score":0.5,"calibrated_materiality_score":0.5,"market_cap_usd":10387135906.5617,"market_cap_bucket":"not_microcap","market_cap_source":"finnhub_profile2","market_cap_as_of_date":"2026-05-28","daily_digest_date":null,"daily_digest_url":null,"daily_digest_rank":null},{"id":327067,"accession_number":"0000785161-23-000015","cik":785161,"company_name":"Encompass Health Corp","ticker":"EHC","form_type":"8-K","filed_at":"2023-02-27T23:59:59+00:00","items":["5.02"],"status":"ready","headline":"Encompass Health amends LTIP with TSR modifier, adds retirement clause; grants $2.83M in restricted stock","summary_kind":"llm","event_type":"other_material","confidence":"high","bullets":["LTIP awards now include relative TSR modifier: 75th percentile multiplies shares by 1.25 (capped at 200% of target), 25th percentile by 0.75.","New 'good leaver' retirement clause allows full vesting upon retirement if conditions met (180-day notice, no violation, cooperation).","One-time restricted stock grants: Douglas Coltharp $1.925M, Patrick Darby $908,000, cliff-vest at 3 years.","One-time grants do not include the retirement clause."],"consensus_eps_estimate":null,"consensus_eps_actual":null,"consensus_revenue_estimate":null,"consensus_revenue_actual":null,"consensus_period":null,"consensus_source":null,"sentiment":"neutral","materiality_score":0.4,"calibrated_materiality_score":0.4,"market_cap_usd":10387135906.5617,"market_cap_bucket":"not_microcap","market_cap_source":"finnhub_profile2","market_cap_as_of_date":"2026-05-28","daily_digest_date":null,"daily_digest_url":null,"daily_digest_rank":null},{"id":327066,"accession_number":"0000785161-23-000007","cik":785161,"company_name":"Encompass Health Corp","ticker":"EHC","form_type":"8-K","filed_at":"2023-02-09T23:59:59+00:00","items":["7.01"],"status":"ready","headline":"Encompass Health corrects EPOB sensitivity and Owasso de novo bed count","summary_kind":"llm","event_type":"other_material","confidence":"high","bullets":["Clarified that a 0.01 change in employees per occupied bed impacts annual Adj. EBITDA by $6-$8M, not 0.05.","Corrected Owasso, OK de novo hospital bed count from 60 to 40.","Reiterated that a 0.05 change in average length of stay impacts Adj. EBITDA by $8-$10M."],"consensus_eps_estimate":null,"consensus_eps_actual":null,"consensus_revenue_estimate":null,"consensus_revenue_actual":null,"consensus_period":null,"consensus_source":null,"sentiment":"neutral","materiality_score":0.5,"calibrated_materiality_score":0.5,"market_cap_usd":10387135906.5617,"market_cap_bucket":"not_microcap","market_cap_source":"finnhub_profile2","market_cap_as_of_date":"2026-05-28","daily_digest_date":null,"daily_digest_url":null,"daily_digest_rank":null},{"id":327065,"accession_number":"0000785161-23-000003","cik":785161,"company_name":"Encompass Health Corp","ticker":"EHC","form_type":"8-K","filed_at":"2023-02-07T23:59:59+00:00","items":["2.02","7.01","9.01"],"status":"ready","headline":"Encompass Health files Q4/FY 2022 results; provides Q1 2023 trend update","summary_kind":"llm","event_type":"earnings","confidence":"low","bullets":["Inpatient rehabilitation discharge growth remained strong in January 2023.","Winter storm activity in early February caused disruptions in some markets.","Company anticipates seasonal fluctuations from spring break in March.","Earnings press release and supplemental slides provided as exhibits (specific financials not reproduced)."],"consensus_eps_estimate":null,"consensus_eps_actual":2.7,"consensus_revenue_estimate":null,"consensus_revenue_actual":4348600000.0,"consensus_period":"2022-FY","consensus_source":"xbrl_only","sentiment":"neutral","materiality_score":0.5,"calibrated_materiality_score":0.5,"market_cap_usd":10387135906.5617,"market_cap_bucket":"not_microcap","market_cap_source":"finnhub_profile2","market_cap_as_of_date":"2026-05-28","daily_digest_date":null,"daily_digest_url":null,"daily_digest_rank":null},{"id":344802,"accession_number":"0000785161-22-000053","cik":785161,"company_name":"Encompass Health Corp","ticker":"EHC","form_type":"8-K","filed_at":"2022-12-13T23:59:59+00:00","items":["5.03","9.01"],"status":"ready","headline":"Encompass Health amends bylaws with universal proxy, exclusive forum, virtual meeting provisions","summary_kind":"llm","event_type":"other_material","confidence":"high","bullets":["Stockholder nominees must comply with SEC Rule 14a-19; noncompliance disqualifies nominees.","Exclusive federal court jurisdiction added for claims under Securities Act of 1933.","Officer appointment structure simplified; Chairman of Board no longer a required officer.","Directors and officers may receive expense advancement to fullest extent permitted by law.","Bylaws updated to allow virtual stockholder meetings per amended DGCL Sections 211 and 219."],"consensus_eps_estimate":null,"consensus_eps_actual":null,"consensus_revenue_estimate":null,"consensus_revenue_actual":null,"consensus_period":null,"consensus_source":null,"sentiment":"neutral","materiality_score":0.25,"calibrated_materiality_score":0.25,"market_cap_usd":10387135906.5617,"market_cap_bucket":"not_microcap","market_cap_source":"finnhub_profile2","market_cap_as_of_date":"2026-05-28","daily_digest_date":null,"daily_digest_url":null,"daily_digest_rank":null},{"id":344801,"accession_number":"0000785161-22-000050","cik":785161,"company_name":"Encompass Health Corp","ticker":"EHC","form_type":"8-K","filed_at":"2022-11-14T23:59:59+00:00","items":["7.01"],"status":"ready","headline":"Encompass Health reaffirms FY2022 guidance at Mizuho CEO Insight Series","summary_kind":"llm","event_type":"other_material","confidence":"high","bullets":["Reiterates FY2022 net operating revenues guidance of $4.32B to $4.35B.","Reaffirms adjusted EBITDA guidance of $800M to $820M.","Reaffirms adjusted EPS from continuing ops guidance of $2.71 to $2.86.","CEO Mark Tarr participating in Mizuho CEO Insight Series on Nov 14, 2022."],"consensus_eps_estimate":null,"consensus_eps_actual":null,"consensus_revenue_estimate":null,"consensus_revenue_actual":null,"consensus_period":null,"consensus_source":null,"sentiment":"neutral","materiality_score":0.3,"calibrated_materiality_score":0.3,"market_cap_usd":10387135906.5617,"market_cap_bucket":"not_microcap","market_cap_source":"finnhub_profile2","market_cap_as_of_date":"2026-05-28","daily_digest_date":null,"daily_digest_url":null,"daily_digest_rank":null},{"id":344800,"accession_number":"0000785161-22-000045","cik":785161,"company_name":"Encompass Health Corp","ticker":"EHC","form_type":"8-K","filed_at":"2022-10-26T23:59:59+00:00","items":["2.02","7.01","9.01"],"status":"ready","headline":"Encompass Health files Q3 2022 earnings 8-K; no specific results in provided text","summary_kind":"llm","event_type":"earnings","confidence":"low","bullets":["Filing body contains only non-GAAP definitions and forward-looking statements; no earnings numbers are present.","Attached exhibits (press release and supplemental slides) are referenced but not included in the input.","Without the exhibits, no financial data, guidance, or operational metrics can be extracted."],"consensus_eps_estimate":null,"consensus_eps_actual":1.81,"consensus_revenue_estimate":null,"consensus_revenue_actual":3211300000.0,"consensus_period":"2022-Q3","consensus_source":"xbrl_only","sentiment":"neutral","materiality_score":0.0,"calibrated_materiality_score":0.0,"market_cap_usd":10387135906.5617,"market_cap_bucket":"not_microcap","market_cap_source":"finnhub_profile2","market_cap_as_of_date":"2026-05-28","daily_digest_date":null,"daily_digest_url":null,"daily_digest_rank":null},{"id":344799,"accession_number":"0000785161-22-000042","cik":785161,"company_name":"Encompass Health Corp","ticker":"EHC","form_type":"8-K","filed_at":"2022-10-13T23:59:59+00:00","items":["1.01","2.03","9.01"],"status":"ready","headline":"Encompass Health enters $1B revolving credit facility; maturity extended to 2027","summary_kind":"llm","event_type":"debt","confidence":"high","bullets":["Sixth Amended and Restated Credit Agreement dated Oct 7, 2022; revolving maturity extended to Oct 7, 2027.","Reference rate changed from LIBOR to SOFR; undrawn commitment fee reduced from 37.5 bps to 25-30 bps.","Maximum leverage ratio set at 4.75x through Sept 2024, then 4.50x; includes step-up election for acquisitions.","Available Amount includes $900M starter plus 50% of cumulative Consolidated Net Income.","No term loans outstanding; ~$40M revolver drawn out of $1B total capacity as of amendment date."],"consensus_eps_estimate":null,"consensus_eps_actual":null,"consensus_revenue_estimate":null,"consensus_revenue_actual":null,"consensus_period":null,"consensus_source":null,"sentiment":"neutral","materiality_score":0.5,"calibrated_materiality_score":0.5,"market_cap_usd":10387135906.5617,"market_cap_bucket":"not_microcap","market_cap_source":"finnhub_profile2","market_cap_as_of_date":"2026-05-28","daily_digest_date":null,"daily_digest_url":null,"daily_digest_rank":null},{"id":361279,"accession_number":"0000785161-22-000036","cik":785161,"company_name":"Encompass Health Corp","ticker":"EHC","form_type":"8-K","filed_at":"2022-08-01T23:59:59+00:00","items":["2.02","7.01","9.01"],"status":"ready","headline":"Encompass Health files Q2 2022 results; specific figures not available in provided text","summary_kind":"llm","event_type":"earnings","confidence":"low","bullets":["Filing references press release (Ex-99.1) and supplemental slides (Ex-99.2), but exhibit content not appended.","No financial data (revenue, EPS, guidance) present in filing body.","Company discusses non-GAAP measures and forward-looking statements; no actual numbers.","Earnings call scheduled for August 2, 2022, at 10:00 AM ET.","Because exhibits are missing, material impact cannot be assessed."],"consensus_eps_estimate":null,"consensus_eps_actual":1.36,"consensus_revenue_estimate":null,"consensus_revenue_actual":2664100000.0,"consensus_period":"2022-Q2","consensus_source":"xbrl_only","sentiment":"neutral","materiality_score":0.2,"calibrated_materiality_score":0.2,"market_cap_usd":10387135906.5617,"market_cap_bucket":"not_microcap","market_cap_source":"finnhub_profile2","market_cap_as_of_date":"2026-05-28","daily_digest_date":null,"daily_digest_url":null,"daily_digest_rank":null},{"id":361278,"accession_number":"0000785161-22-000034","cik":785161,"company_name":"Encompass Health Corp","ticker":"EHC","form_type":"8-K","filed_at":"2022-07-07T23:59:59+00:00","items":["1.01","2.01","9.01"],"status":"ready","headline":"Encompass Health completes spin-off of home health/hospice business into Enhabit","summary_kind":"llm","event_type":"other_material","confidence":"high","bullets":["Distribution effective July 1, 2022; one Enhabit share for every two EHC shares held on June 24, 2022.","Enhabit is now an independent public company trading on NYSE under symbol 'EHAB'.","Encompass Health entered into Separation, Transition Services, Tax Matters, and Employee Matters agreements.","Pro forma financials reflect Enhabit as discontinued operations for all periods presented.","No fractional shares distributed; cash in lieu of fractions will be paid."],"consensus_eps_estimate":null,"consensus_eps_actual":null,"consensus_revenue_estimate":null,"consensus_revenue_actual":null,"consensus_period":null,"consensus_source":null,"sentiment":"neutral","materiality_score":0.75,"calibrated_materiality_score":0.75,"market_cap_usd":10387135906.5617,"market_cap_bucket":"not_microcap","market_cap_source":"finnhub_profile2","market_cap_as_of_date":"2026-05-28","daily_digest_date":null,"daily_digest_url":null,"daily_digest_rank":null},{"id":380540,"accession_number":"0001140361-22-023676","cik":785161,"company_name":"Encompass Health Corp","ticker":"EHC","form_type":"8-K","filed_at":"2022-06-21T23:59:59+00:00","items":["7.01","9.01"],"status":"ready","headline":"Encompass Health's spin-off of Enhabit effective; distribution ratio 1:2, record June 24, distribution July 1","summary_kind":"llm","event_type":"other_material","confidence":"high","bullets":["Form 10 for Enhabit, Inc. became effective June 17, 2022; final information statement issued June 21.","Distribution: 1 share of Enhabit common stock for every 2 shares of Encompass common stock held as of June 24.","Distribution expected to occur at 12:01 a.m. ET on July 1, 2022, subject to conditions.","Enhabit common stock to trade when-issued (EHAB WI) from June 23 to June 30; regular-way (EHAB) begins July 1.","Encompass common stock to trade regular-way (EHC) and ex-distribution (EHC WI) during June 23-30."],"consensus_eps_estimate":null,"consensus_eps_actual":null,"consensus_revenue_estimate":null,"consensus_revenue_actual":null,"consensus_period":null,"consensus_source":null,"sentiment":"neutral","materiality_score":0.7,"calibrated_materiality_score":0.7,"market_cap_usd":10387135906.5617,"market_cap_bucket":"not_microcap","market_cap_source":"finnhub_profile2","market_cap_as_of_date":"2026-05-28","daily_digest_date":null,"daily_digest_url":null,"daily_digest_rank":null},{"id":380539,"accession_number":"0000785161-22-000031","cik":785161,"company_name":"Encompass Health Corp","ticker":"EHC","form_type":"8-K","filed_at":"2022-06-13T23:59:59+00:00","items":["7.01","9.01"],"status":"ready","headline":"Encompass Health holds virtual non-deal roadshow for Enhabit segment","summary_kind":"llm","event_type":"other_material","confidence":"low","bullets":["Enhabit CEO Barbara Jacobsmeyer and CFO Crissy Carlisle to present at virtual roadshow starting June 13, 2022.","Presentation includes forward-looking estimates about the planned tax-free spin-off of Enhabit.","No specific financial results or updated guidance disclosed in the filing or provided exhibit text."],"consensus_eps_estimate":null,"consensus_eps_actual":null,"consensus_revenue_estimate":null,"consensus_revenue_actual":null,"consensus_period":null,"consensus_source":null,"sentiment":"neutral","materiality_score":0.25,"calibrated_materiality_score":0.25,"market_cap_usd":10387135906.5617,"market_cap_bucket":"not_microcap","market_cap_source":"finnhub_profile2","market_cap_as_of_date":"2026-05-28","daily_digest_date":null,"daily_digest_url":null,"daily_digest_rank":null}],"next_cursor":"2022-06-13T23:59:59+00:00|380539"}